This is a preview of subscription content, log in via an institution to check access.
Notes
incremental cost-effectiveness ratio
Reference
Linas BP, et al. The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients. AIDS 28: 365-76, No. 3, 28 Jan 2014. Available from: URL: http://doi.org/10.1097/QAD.0000000000000093
Rights and permissions
About this article
Cite this article
Double beats triple in hep C therapy. PharmacoEcon Outcomes News 700, 5 (2014). https://doi.org/10.1007/s40274-014-1165-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1165-8